Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Endocrine comorbidities of pediatric obesity

  • Lee, Jieun (Department of Pediatrics, Inje University Ilsan Paik Hospital) ;
  • Kim, Jae Hyun (Department of Pediatrics, Seoul National University Bundang Hospital)
  • Received : 2021.02.23
  • Accepted : 2021.08.19
  • Published : 2021.12.15
Download PDF
⟨ Previous Next ⟩

Abstract

Pediatric obesity has become a serious public health issue. The prevalence of obesity in children and adolescents has increased worldwide and in Korea over several decades. Obese children are more likely to be obese adults with an increased cardiovascular risk. Therefore, maintaining a healthy weight and preventing obesity during childhood are of critical importance. Moreover, obese children and adolescents often have endocrine comorbidities such as prediabetes, type 2 diabetes, dyslipidemia, metabolic syndrome, polycystic ovary syndrome, and central precocious puberty. Hence, the early implementation of obesity management using a multidisciplinary team approach and screening for these comorbidities in obese children and adolescents are required with the appropriate management of each comorbidity and/or specialist referral.

Keywords

References

  1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
  2. Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, et al. Pediatric obesity-assessment, treatment, and prevention: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2017;102:709-57. https://doi.org/10.1210/jc.2016-2573
  3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 2017;390:2627-42. https://doi.org/10.1016/S0140-6736(17)32129-3
  4. Oh K, Jang MJ, Lee NY, Moon JS, Lee CG, Yoo MH, et al. Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005. Clin Exp Pediatr 2008;51:950-5. https://doi.org/10.3345/kjp.2008.51.9.950
  5. Kim JH, Moon JS. Secular trends in pediatric overweight and obesity in Korea. J Obes Metab Syndr 2020;29:12-7. https://doi.org/10.7570/jomes20002
  6. Nam HK, Kim HR, Rhie YJ, Lee KH. Trends in the prevalence of extreme obesity among Korean children and adolescents from 2001 to 2014. J Pediatr Endocrinol Metab 2017;30:517-23. https://doi.org/10.1515/jpem-2016-0456
  7. Simmonds M, Llewellyn A, Owen CG, Woolacott N. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes Rev 2016;17:95-107. https://doi.org/10.1111/obr.12334
  8. Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med 2015;373:1307-17. https://doi.org/10.1056/NEJMoa1502821
  9. Weihe P, Spielmann J, Kielstein H, Henning-Klusmann J, WeihrauchBluher S. Childhood obesity and cancer risk in adulthood. Curr Obes Rep 2020;9:204-12. https://doi.org/10.1007/s13679-020-00387-w
  10. Weihrauch-Bluher S, Schwarz P, Klusmann JH. Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood. Metabolism 2019;92:147-52. https://doi.org/10.1016/j.metabol.2018.12.001
  11. Sonntag D, Ali S, De Bock F. Lifetime indirect cost of childhood overweight and obesity: A decision analytic model. Obesity (Silver Spring) 2016;24:200-6. https://doi.org/10.1002/oby.21323
  12. Sonntag D, Ali S, Lehnert T, Konnopka A, Riedel-Heller S, Konig HH. Estimating the lifetime cost of childhood obesity in Germany: results of a Markov model. Pediatr Obes 2015;10:416-22. https://doi.org/10.1111/ijpo.278
  13. Castorani V, Polidori N, Giannini C, Blasetti A, Chiarelli F. Insulin resistance and type 2 diabetes in children. Ann Pediatr Endocrinol Metab 2020;25:217-26. https://doi.org/10.6065/apem.2040090.045
  14. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 2021;44:S15-33. https://doi.org/10.2337/dc21-s002
  15. Abbasi A, Juszczyk D, van Jaarsveld CHM, Gulliford MC. Body mass index and incident type 1 and type 2 diabetes in children and young adults: a retrospective cohort study. J Endocr Soc 2017;1:524-37. https://doi.org/10.1210/js.2017-00044
  16. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009;58:773-95. https://doi.org/10.2337/db09-9028
  17. Valaiyapathi B, Gower B, Ashraf AP. Pathophysiology of type 2 diabetes in children and adolescents. Curr Diabetes Rev 2020;16:220-9. https://doi.org/10.2174/1573399814666180608074510
  18. Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev 2013;9:25-53. https://doi.org/10.2174/157339913804143225
  19. Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P. Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association. Diabetes Care 2018;41:2648-68. https://doi.org/10.2337/dci18-0052
  20. Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab 2011;96:159-67. https://doi.org/10.1210/jc.2010-1642
  21. Lee J, Lee YA, Kim JH, Lee SY, Shin CH, Yang SW. Discrepancies between glycosylated hemoglobin and fasting plasma glucose for diagnosing impaired fasting glucose and diabetes mellitus in Korean youth and young adults. Diabetes Metab J 2019;43:174-82. https://doi.org/10.4093/dmj.2018.0046
  22. Zeitler P, Arslanian S, Fu J, Pinhas-Hamiel O, Reinehr T, Tandon N, et al. ISPAD Clinical Practice Consensus Guidelines 2018: type 2 diabetes mellitus in youth. Pediatr Diabetes 2018;19 Suppl 27:28-46. https://doi.org/10.1111/pedi.12719
  23. Brar PC. Update on the current modalities used to screen high risk youth for prediabetes and/or type 2 diabetes mellitus. Ann Pediatr Endocrinol Metab 2019;24:71-7. https://doi.org/10.6065/apem.2019.24.2.71
  24. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996;128:608-15. https://doi.org/10.1016/S0022-3476(96)80124-7
  25. Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell RA, D'Agostino RB Jr, Imperatore G, Johansen JM, et al. Incidence of diabetes in youth in the United States. JAMA 2007;297:2716-24. https://doi.org/10.1001/jama.297.24.2716
  26. Andes LJ, Cheng YJ, Rolka DB, Gregg EW, Imperatore G. Prevalence of prediabetes among adolescents and young adults in the United States, 2005-2016. JAMA Pediatr 2020;174:e194498. https://doi.org/10.1001/jamapediatrics.2019.4498
  27. Cho EH, Shin D, Cho KH, Hur J. Prevalences and management of diabetes and pre-diabetes among Korean teenagers and young adults: results from the Korea National Health and Nutrition Examination Survey 2005-2014. J Korean Med Sci 2017;32:1984-90. https://doi.org/10.3346/jkms.2017.32.12.1984
  28. Kim MS, Kim JH. Cardiometabolic risk factors and metabolic syndrome by severity of obesity in Korean children and adolescents: data from the Korea National Health and Nutrition Examination Survey 2007-2018 [Abstract]. In: KSSO Annual Spring Conference 2021; 2021 March 26-27; Seoul, Korea.
  29. Magge SN, Silverstein J, Elder D, Nadeau K, Hannon TS. Evaluation and treatment of prediabetes in youth. J Pediatr 2020;219:11-22. https://doi.org/10.1016/j.jpeds.2019.12.061
  30. American Diabetes Association. 13. Children and adolescents: standards of medical care in diabetes-2021. Diabetes Care 2021;44:S180-99. https://doi.org/10.2337/dc21-s013
  31. DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K, et al. ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes 2018;19 Suppl 27:105-14. https://doi.org/10.1111/pedi.12737
  32. Tamborlane WV, Barrientos-Perez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, et al. Liraglutide in children and adolescents with type 2 diabetes. N Engl J Med 2019;381:637-46. https://doi.org/10.1056/NEJMoa1903822
  33. Bolling CF, Armstrong SC, Reichard KW, Michalsky MP, Section on Obesity SOS. Metabolic and bariatric surgery for pediatric patients with severe obesity. Pediatrics 2019;144:e20193224. https://doi.org/10.1542/peds.2019-3224
  34. Donaghue KC, Marcovecchio ML, Wadwa RP, Chew EY, Wong TY, Calliari LE, et al. ISPAD Clinical Practice Consensus Guidelines 2018:microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes 2018;19 Suppl 27:262-74. https://doi.org/10.1111/pedi.12742
  35. Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med 2017;167:ITC81-96. https://doi.org/10.7326/AITC201712050
  36. McGill HC Jr, McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000;20:1998-2004. https://doi.org/10.1161/01.ATV.20.8.1998
  37. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. Pediatrics 2011;128 Suppl 5(Suppl 5):S213-56. https://doi.org/10.1542/peds.2009-2107C
  38. Lim JS, Kim EY, Kim JH, Yoo JH, Yi KH, Chae HW, et al. 2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents. Ann Pediatr Endocrinol Metab 2020;25:199-207. https://doi.org/10.6065/apem.2040198.099
  39. Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. Obesity and dyslipidemia. Metabolism 2019;92:71-81. https://doi.org/10.1016/j.metabol.2018.11.005
  40. Yang S, Hwang JS, Park HK, Lee HS, Kim HS, Kim EY, et al. Serum lipid concentrations, prevalence of dyslipidemia, and percentage eligible for pharmacological treatment of Korean children and adolescents; data from the Korea National Health and Nutrition Examination Survey IV (2007-2009). PLoS One 2012;7:e49253. https://doi.org/10.1371/journal.pone.0049253
  41. Kit BK, Kuklina E, Carroll MD, Ostchega Y, Freedman DS, Ogden CL. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr 2015;169:272-9. https://doi.org/10.1001/jamapediatrics.2014.3216
  42. Shin JH, Cheong JI, Cheuh HW, Yoo JH. Limitations of current screening methods for lipid disorders in Korean adolescents and a proposal for an effective detection method: a nationwide, cross-sectional study. Ann Pediatr Endocrinol Metab 2020;25:265-71. https://doi.org/10.6065/apem.2040098.049
  43. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. https://doi.org/10.2337/diabetes.37.12.1595
  44. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421. https://doi.org/10.1161/circ.106.25.3143
  45. Wang HH, Lee DK, Liu M, Portincasa P, Wang DQ. Novel insights into the pathogenesis and management of the metabolic syndrome. Pediatr Gastroenterol Hepatol Nutr 2020;23:189-230. https://doi.org/10.5223/pghn.2020.23.3.189
  46. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-7. https://doi.org/10.1001/archpedi.157.8.821
  47. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007;8:299-306. https://doi.org/10.1111/j.1399-5448.2007.00271.x
  48. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004;110:2494-7. https://doi.org/10.1161/01.CIR.0000145117.40114.C7
  49. Reisinger C, Nkeh-Chungag BN, Fredriksen PM, Goswami N. The prevalence of pediatric metabolic syndrome-a critical look on the discrepancies between definitions and its clinical importance. Int J Obes (Lond) 2021;45:12-24. https://doi.org/10.1038/s41366-020-00713-1
  50. Moon S, Park JS, Ahn Y. The cut-off values of triglycerides and glucose index for metabolic syndrome in American and Korean adolescents. J Korean Med Sci 2017;32:427-33. https://doi.org/10.3346/jkms.2017.32.3.427
  51. Kim S, So WY. Prevalence of metabolic syndrome among Korean adolescents according to the National Cholesterol Education Program, Adult Treatment Panel III and International Diabetes Federation. Nutrients 2016;8:588. https://doi.org/10.3390/nu8100588
  52. Seo JY, Kim JH. Validation of surrogate markers for metabolic syndrome and cardiometabolic risk factor clustering in children and adolescents: a nationwide population-based study. PLoS One 2017;12:e0186050. https://doi.org/10.1371/journal.pone.0186050
  53. Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care 2008;31:587-9. https://doi.org/10.2337/dc07-1030
  54. Tagi VM, Giannini C, Chiarelli F. Insulin resistance in children. Front Endocrinol (Lausanne) 2019;10:342. https://doi.org/10.3389/fendo.2019.00342
  55. Wittcopp C, Conroy R. Metabolic syndrome in children and adolescents. Pediatr Rev 2016;37:193-202. https://doi.org/10.1542/pir.2014-0095
  56. Magnussen CG, Koskinen J, Chen W, Thomson R, Schmidt MD, Srinivasan SR, et al. Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. Circulation 2010;122:1604-11. https://doi.org/10.1161/CIRCULATIONAHA.110.940809
  57. Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 2007;120:340-5. https://doi.org/10.1542/peds.2006-1699
  58. Tagi VM, Samvelyan S, Chiarelli F. Treatment of metabolic syndrome in children. Horm Res Paediatr 2020;93:215-25. https://doi.org/10.1159/000510941
  59. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017;140:e20171904. https://doi.org/10.1542/peds.2017-1904
  60. Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev 2015;36:487-525. https://doi.org/10.1210/er.2015-1018
  61. Wang S, Alvero R. Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome. Semin Reprod Med 2013;31:365-9. https://doi.org/10.1055/s-0033-1348895
  62. Naz MSG, Tehrani FR, Majd HA, Ahmadi F, Ozgoli G, Fakari FR, et al. The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis. Int J Reprod Biomed 2019;17:533-42.
  63. Trent M, Austin SB, Rich M, Gordon CM. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005;5:107-11. https://doi.org/10.1367/A04-130R.1
  64. Dokras A, Clifton S, Futterweit W, Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol 2011;117:145-52. https://doi.org/10.1097/AOG.0b013e318202b0a4
  65. Dokras A, Clifton S, Futterweit W, Wild R. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 2012;97:225-30.e2. https://doi.org/10.1016/j.fertnstert.2011.10.022
  66. Fields EL, Trent ME. Treatment considerations for the cardiometabolic signs of polycystic ovary syndrome: a review of the literature since the 2013 Endocrine Society Clinical practice guidelines. JAMA Pediatr 2016;170:502-7. https://doi.org/10.1001/jamapediatrics.2015.4866
  67. Ibanez L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, et al. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr 2017;88:371-95. https://doi.org/10.1159/000479371
  68. Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril 2018;110:794-809. https://doi.org/10.1016/j.fertnstert.2018.08.021
  69. Trent M, Gordon CM. Diagnosis and management of polycystic ovary syndrome in adolescents. Pediatrics 2020;145:S210-8. https://doi.org/10.1542/peds.2019-2056j
  70. Kostopoulou E, Anagnostis P, Bosdou JK, Spiliotis BE, Goulis DG. Polycystic ovary syndrome in adolescents: pitfalls in diagnosis and management. Curr Obes Rep 2020;9:193-203. https://doi.org/10.1007/s13679-020-00388-9
  71. Carel JC, Leger J. Clinical practice. Precocious puberty. N Engl J Med 2008;358:2366-77. https://doi.org/10.1056/NEJMcp0800459
  72. Latronico AC, Brito VN, Carel JC. Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol 2016;4:265-74. https://doi.org/10.1016/S2213-8587(15)00380-0
  73. Burt Solorzano CM, McCartney CR. Obesity and the pubertal transition in girls and boys. Reproduction 2010;140:399-410. https://doi.org/10.1530/REP-10-0119
  74. Brix N, Ernst A, Lauridsen LLB, Parner ET, Arah OA, Olsen J, et al. Childhood overweight and obesity and timing of puberty in boys and girls: cohort and sibling-matched analyses. Int J Epidemiol 2020;49:834-44. https://doi.org/10.1093/ije/dyaa056
  75. Li W, Liu Q, Deng X, Chen Y, Liu S, Story M. Association between obesity and puberty timing: a systematic review and meta-analysis. Int J Environ Res Public Health 2017;14:1266. https://doi.org/10.3390/ijerph14101266
  76. Kim YJ, Kwon A, Jung MK, Kim KE, Suh J, Chae HW, et al. Incidence and prevalence of central precocious puberty in Korea: an epidemiologic study based on a national database. J Pediatr 2019;208:221-8. https://doi.org/10.1016/j.jpeds.2018.12.022
  77. Lee MH, Kim SH, Oh M, Lee KW, Park MJ. Age at menarche in Korean adolescents: trends and influencing factors. Reprod Health 2016;13:121. https://doi.org/10.1186/s12978-016-0240-y
  78. McCartney CR, Blank SK, Prendergast KA, Chhabra S, Eagleson CA, Helm KD, et al. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. J Clin Endocrinol Metab 2007;92:430-6. https://doi.org/10.1210/jc.2006-2002
  79. Nieuwenhuis D, Pujol-Gualdo N, Arnoldussen IAC, Kiliaan AJ. Adipokines: a gear shift in puberty. Obes Rev 2020;21:e13005. https://doi.org/10.1111/obr.13005
  80. Ab Rahim SN, Omar J, Tuan Ismail TS. Gonadotropin-releasing hormone stimulation test and diagnostic cutoff in precocious puberty: a mini review. Ann Pediatr Endocrinol Metab 2020;25:152-5. https://doi.org/10.6065/apem.2040004.002
  81. Bangalore Krishna K, Fuqua JS, Rogol AD, Klein KO, Popovic J, Houk CP, et al. Use of gonadotropin-releasing hormone analogs in children: update by an international consortium. Horm Res Paediatr 2019;91:357-72. https://doi.org/10.1159/000501336
  82. Chi X, Yu D, Ju L, Zhang J, Zhao L. Prevalence of diabetes and change among 7 to 17 years old children and adolescents in China in 2002-2012. Wei Sheng Yan Jiu 2018;47:705-15.
  83. Wang Z, Zou Z, Wang H, Jing J, Luo J, Zhang X, et al. Prevalence and risk factors of impaired fasting glucose and diabetes among Chinese children and adolescents: a national observational study. Br J Nutr 2018;120:813-9. https://doi.org/10.1017/s0007114518002040
  84. Wallace AS, Wang D, Shin JI, Selvin E. Screening and diagnosis of prediabetes and diabetes in US children and adolescents. Pediatrics 2020;146:e20200265. https://doi.org/10.1542/peds.2020-0265
  85. Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014;311:1778-86. https://doi.org/10.1001/jama.2014.3201
  86. Khanolkar AR, Amin R, Taylor-Robinson D, Viner R, Warner J, Stephenson T. Ethnic minorities are at greater risk for childhood-onset type 2 diabetes and poorer glycemic control in England and Wales. J Adolesc Health 2016;59:354-61. https://doi.org/10.1016/j.jadohealth.2016.05.012
  87. Lee JH, Kim YM, Kwak MJ, Kim SY, Kim HJ, Cheon CK, et al. Incidence trends and associated factors of diabetes mellitus in Korean children and adolescents: a retrospective cohort study in Busan and Gyeongnam. Ann Pediatr Endocrinol Metab 2015;20:206-12. https://doi.org/10.6065/apem.2015.20.4.206
  88. Urakami T, Miyata M, Yoshida K, Mine Y, Kuwabara R, Aoki M, et al. Changes in annual incidence of school children with type 2 diabetes in the Tokyo metropolitan area during 1975-2015. Pediatr Diabetes 2018;19:1385-92. https://doi.org/10.1111/pedi.12750
  89. Wu H, Zhong J, Yu M, Wang H, Gong W, Pan J, et al. Incidence and time trends of type 2 diabetes mellitus in youth aged 5-19 years: a populationbased registry in Zhejiang, China, 2007 to 2013. BMC Pediatr 2017;17:85. https://doi.org/10.1186/s12887-017-0834-8
  90. Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med 2017;376:1419-29. https://doi.org/10.1056/NEJMoa1610187
  91. Ding W, Cheng H, Yan Y, Zhao X, Chen F, Huang G, et al. 10-Year trends in serum lipid levels and dyslipidemia among children and adolescents from several schools in Beijing, China. J Epidemiol 2016;26:637-45. https://doi.org/10.2188/jea.JE20140252
  92. Park SI, Suh J, Lee HS, Song K, Choi Y, Oh JS, et al. Ten-year trends of metabolic syndrome prevalence and nutrient intake among Korean children and adolescents: a population-based study. Yonsei Med J 2021;62:344-51. https://doi.org/10.3349/ymj.2021.62.4.344
  93. Xu T, Liu J, Liu J, Zhu G, Han S. Relation between metabolic syndrome and body compositions among Chinese adolescents and adults from a large-scale population survey. BMC Public Health 2017;17:337. https://doi.org/10.1186/s12889-017-4238-3
  94. Vanlancker T, Schaubroeck E, Vyncke K, Cadenas-Sanchez C, Breidenassel C, Gonzalez-Gross M, et al. Comparison of definitions for the metabolic syndrome in adolescents. The HELENA study. Eur J Pediatr 2017;176:241-52. https://doi.org/10.1007/s00431-016-2831-6
  95. Reuter CP, Burgos MS, Barbian CD, Renner JDP, Franke SIR, de Mello ED. Comparison between different criteria for metabolic syndrome in schoolchildren from southern Brazil. Eur J Pediatr 2018;177:1471-7. https://doi.org/10.1007/s00431-018-3202-2